EUVIMEDEUVIMED entdecken
Open Access

The Effect of Glucagon-Like Peptide 1 Receptor Blockade on Glucagon-Induced Stimulation of Insulin Secretion

Rahele A Farahani, Aoife M Egan, Andrew A Welch, Marcello C Laurenti, Claudio Cobelli, Chiara Dalla Man, Adrian Vella iD

Diabetes · 2023

DOI: 10.2337/db22-0709 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, 2023. Verfasst von Rahele A Farahani und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Diabetes & Metabolism, Mayo Clinic College of Medicine, Rochester, MN. Hauptthemen laut MEDLINE: Glucagon, Insulin. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NCATS NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Data from transgenic rodent models suggest that glucagon acts as an insulin secretagogue by signaling through the glucagon-like peptide 1 receptor (GLP-1R) present on β-cells. However, its net contribution to physiologic insulin secretion in humans is unknown. To address this question, we studied individuals without diabetes in two separate experiments. Each subject was studied on two occasions in random order. In the first experiment, during a hyperglycemic clamp, glucagon was infused at 0.4 ng/kg/min, increasing by 0.2 ng/kg/min every hour for 5 h. On one day, exendin-9,39 (300 pmol/kg/min) was infused to block GLP-1R, while on the other, saline was infused. The insulin secretion rate (ISR) was calculated by nonparametric deconvolution from plasma concentrations of C-peptide. Endogenous glucose production and glucose disappearance were measured using the tracer-dilution technique. Glucagon concentrations, by design, did not differ between study days. Integrated ISR was lower during exendin-9,39 infusion (213 ± 26 vs. 191 ± 22 nmol/5 h, saline vs. exendin-9,39, respectively; P = 0.02). In the separate experiment, exendin-9,39 infusion, compared with saline infusion, also decreased the β-cell secretory response to a 1-mg glucagon bolus. These data show that, in humans without diabetes, glucagon partially stimulates the β-cell through GLP-1R.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlucagonInsulinHumansInsulin SecretionGlucagon-Like Peptide-1 ReceptorGlucagon-Like Peptide 1Blood GlucosePeptide FragmentsGlucose

Substanzen

GlucagonInsulinGlucagon-Like Peptide-1 ReceptorGlucagon-Like Peptide 1Blood GlucosePeptide FragmentsGlucose

Autor:innen und Institutionen

  • Division of Endocrinology, Diabetes & Metabolism, Mayo Clinic College of Medicine, Rochester, MN.
  • Biomedical Engineering and Physiology Graduate Program, Mayo Clinic Graduate School of Biomedical Sciences, Rochester, MN.
  • Department of Women's and Children's Health, University of Padova, Padova, Italy.
  • Department of Information Engineering, University of Padova, Padova, Italy.

ORCID-Profile: Adrian Vella

Förderung

  • NIDDK NIH HHS
  • NCATS NIH HHS
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • Mayo Clinic General Clinical Research Center
  • MIUR

Zitieren

APA

Farahani, R. A., Egan, A. M., Welch, A. A., Laurenti, M. C., Cobelli, C., Dalla Man, C., & Vella, A. (2023). The Effect of Glucagon-Like Peptide 1 Receptor Blockade on Glucagon-Induced Stimulation of Insulin Secretion. Diabetes. https://doi.org/10.2337/db22-0709

Vancouver

Farahani RA, Egan AM, Welch AA, Laurenti MC, Cobelli C, Dalla Man C, et al. The Effect of Glucagon-Like Peptide 1 Receptor Blockade on Glucagon-Induced Stimulation of Insulin Secretion. Diabetes. 2023. doi:10.2337/db22-0709

BibTeX
@article{Farahani2023,
  author = {Farahani, Rahele A and Egan, Aoife M and Welch, Andrew A and Laurenti, Marcello C and Cobelli, Claudio and Dalla Man, Chiara and Vella, Adrian},
  title = {The Effect of Glucagon-Like Peptide 1 Receptor Blockade on Glucagon-Induced Stimulation of Insulin Secretion},
  journal = {Diabetes},
  year = {2023},
  doi = {10.2337/db22-0709}
}
Kostenlos starten →